Acute Management of Hypoglycemia

Oral Treatment for Conscious Patients

Administer 15–20 g of rapid‑acting carbohydrate (e.g., four glucose tablets, 120 mL fruit juice, one tablespoon honey, sugary soda, milk, or candy) when capillary glucose is ≤70 mg/dL (3.9 mmol/L), and re‑measure glucose after 15 minutes, repeating the dose if hypoglycemia persists. Clinical improvement should be evident within 15–20 minutes, making rapid symptom resolution a practical diagnostic clue. 1
The glycemic response to oral carbohydrate is transient (usually <2 hours) in insulin‑induced hypoglycemia; therefore a substantial snack or meal should be taken shortly after glucose normalization to maintain euglycemia. 1
Avoid post‑treatment hyperglycemia after severe or prolonged episodes, as excessive rebound glucose may contribute to neuronal injury. 1

Use glucagon 1 mg subcutaneously or intramuscularly (administered by a caregiver) for patients unable to ingest carbohydrates; it can be life‑saving but often produces a temporary marked hyperglycemia and may cause nausea or vomiting. 1
If medical personnel are present, give 25 g of intravenous glucose as the standard initial dose; the glucose rise is also transient, so oral feeding should be resumed as soon as the patient can safely swallow. 1

More than 50 % of real‑world hypoglycemia episodes are overtreated, with patients consuming >20 g of carbohydrate; 22.3 % receive >30 g, increasing the risk of rebound hyperglycemia. Patient education emphasizing the 15–20 g dose is essential to prevent this. 1

The duration of a hypoglycemic event depends on its etiology; for example, alcohol intake can lower plasma glucose concentrations, prolonging the episode. 2

Without a fundamental change in the therapeutic regimen, the likelihood of another severe hypoglycemic event remains high. Strategies include:
- Switching to a different secretagogue or insulin formulation. 2
- Reducing the dose of secretagogues or insulin. 2
- Temporarily accepting higher glucose targets to enhance safety. 2
For individuals with impaired hypoglycemia awareness, a 2–3‑week period of strict hypoglycemia avoidance is recommended to help restore awareness; this intervention is intended to last weeks rather than months. [1][2]

Hypoglycemia typically causes functional cerebral failure that resolves in the majority of cases once plasma glucose is restored. 1
Deep, prolonged hypoglycemia can cause irreversible brain injury or death; therefore, plasma glucose must be rapidly corrected to normal levels. 1

The classic autonomic (sweating, tremor, feeling terrible) and neuroglycopenic (dizziness, confusion) symptoms together define hypoglycemia and are most reliably identified when they resolve rapidly after carbohydrate ingestion【3】【4】.
Rapid symptom relief after eating is considered pathognomonic for hypoglycemia and helps differentiate it from vestibular, cardiac, or neurologic causes of dizziness【4】.

Documenting a blood glucose concentration ≤ 70 mg/dL (3.9 mmol/L) during a symptomatic episode confirms hypoglycemia and satisfies the “alert value” component of Whipple’s triad【3】【4】.
Severity can be graded:
- Level 1 – glucose 54–70 mg/dL,
- Level 2 – glucose < 54 mg/dL,
- Level 3 – severe cognitive impairment requiring assistance【3】.
The most frequent etiologies are insulin, sulfonylureas, and meglitinides; a thorough medication review is therefore essential【3】【4】.
Alcohol consumption, especially without adequate food intake, is a recognized precipitant of hypoglycemia【4】.
Unexplained weight loss may indicate an insulin‑producing tumor (insulinoma) and should prompt targeted evaluation【4】.

Acute treatment: Administer ≈ 15 g of fast‑acting carbohydrate (e.g., 4 glucose tablets, 4 oz fruit juice, or 1 Tbsp honey) when glucose is ≤70 mg/dL【3】【4】.
Re‑assessment: Re‑measure glucose after 15 minutes; repeat carbohydrate dosing if hypoglycemia persists【3】【4】.
Dietary considerations: Avoid protein‑rich or fat‑containing foods during the acute phase because they delay glucose absorption and may stimulate insulin secretion【3】【4】.
Glucagon: For patients on insulin or at high risk of severe episodes, prescribe a ready‑to‑use glucagon formulation (intranasal or auto‑injector) and ensure caregivers are trained in its administration【3】【4】.

In patients using diabetes medications, adjust the therapeutic regimen to prevent recurrence【3】【4】.
For individuals without an obvious cause, a supervised 72‑hour fast is recommended to detect insulinoma or other fasting‑related disorders【4】.
Targeted screening for adrenal insufficiency, hypothyroidism, and hepatic disease should be performed when clinical clues are present【4】.

Do not dismiss hypoglycemic symptoms as anxiety or panic attacks without objective glucose documentation【3】.
Do not overlook hypoglycemia induced by medications not traditionally associated with glucose lowering (e.g., fluoroquinolones)【4】.
Frequent or severe hypoglycemic episodes markedly increase the risk of future life‑threatening events; prompt evaluation and intervention are therefore critical【3】.